UK markets close in 1 hour 41 minutes

Edesa Biotech, Inc. (EDSA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.6400+0.1000 (+2.20%)
As of 09:35AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Cash flows from operating activities
Net income
-7,245
-8,374
-17,549
-13,343
-6,364
-
Depreciation & amortisation
219.397
183.471
118.188
118.788
57.563
-
Stock-based compensation
959.289
1,246
2,261
3,195
598.359
-
Change in working capital
-258.819
308.004
2,891
-3,636
721.968
-
Inventory
0
-
-
-
0
77.913
Other working capital
-6,340
-6,636
-12,285
-13,671
-5,021
-
Other non-cash items
655.922
-
-
-
-
-
Net cash provided by operating activities
-6,340
-6,636
-12,279
-13,665
-4,986
-
Cash flows from investing activities
Investments in property, plant and equipment
-34.339
-
-5.656
-6.146
-34.339
-8.095
Purchases of investments
-
-
-
0
-500
0
Sales/maturities of investments
500
-
-
0
500
0
Net cash used for investing activities
-
0
-5.656
-6.146
19.073
-
Cash flows from financing activities
Common stock issued
1,909
4,345
11,958
12,662
4,361
-
Other financing activities
-532.874
-285.438
-328.059
-188.366
-532.874
-
Net cash used provided by (used for) financing activities
1,671
4,830
11,630
14,175
7,093
-
Net change in cash
-4,672
-1,730
-748.34
625.564
2,183
-
Cash at beginning of period
7,471
7,091
7,839
7,214
5,031
-
Cash at end of period
2,802
5,361
7,091
7,839
7,214
-
Free cash flow
Operating cash flow
-6,340
-6,636
-12,279
-13,665
-4,986
-
Capital expenditure
-34.339
-
-5.656
-6.146
-34.339
-8.095
Free cash flow
-6,340
-6,636
-12,285
-13,671
-5,021
-